Dupont Nutrition Biosciences APS
USPTO PatentsView assignee record - 102 granted patents across 50 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).
The verdict
According to USPTO PatentsView, Dupont ranks #3,593 of 49,997 tracked US assignees by granted-patent volume, with 102 patents across 50 technology areas.
- #3,593
- of 49,997 US assignees by volume
- Top 6%
- by Innovation Score (56.1/100)
- 16.3
- avg claims per patent
- -52%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R3593 · Foreign Corporation #3,593 · 102 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MID 102 grants
- TOP-DECILE #3,593/49,997
- PHOTO-FINISH Bostik
- CPC-WIDE C12N · 50 areas
- INNOV-PAR 56.1/100
- CLAIMS-RICH 16.3 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -52% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Bostik SA (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Dupont’s 56.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Dupont
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Daiichi Sankyo · near
Daiichi Sankyo · near
56 score
- Dupont Nutrition… · this assignee
Dupont Nutrition… · this assignee
56 score
- Electricite DE France · near
Electricite DE France · near
56 score
- Gaztransport ET… · near
Gaztransport ET… · near
56 score
- Liebherr-aerospace… · near
Liebherr-aerospace… · near
56 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Dupont's Innovation Score is 56.1/100 (top 6% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Dupont?
Each dot is one of Dupont’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Dupont’s own 16.3 claims/patent is ABOVE the 14.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
How Dupont's grant cadence moved
Between 2020–2024, Dupont Nutrition Biosciences APS received 33 grants versus 69 in 2015–2019 (-52% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2015 at 23 grants and bottomed in 2021 at 3. Lead class C12N accounts for 59.8% of the portfolio across 50 subclasses. Volume neighbours: Bostik SA (#3,589) and Inficon AG (#3,597).
Dupont's three-year grant acceleration
From 2019–2021 to 2022–2024, Dupont Nutrition Biosciences APS moved from 24 to 19 grants (0.79x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,870. See the growth leaderboard.
Who files at Dupont's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Bostik
Bostik SA
102 patents
- Central South Uni…
Central South University
102 patents
- Colder Products
Colder Products Company
102 patents
- Corcept Therapeut…
Corcept Therapeutics Incorporated
102 patents
- G D Societa' PER…
G.D Societa' PER Azioni
102 patents
- Genesis Photonics
Genesis Photonics Inc.
102 patents
- H C Starck
H.C. Starck Inc.
102 patents
- Inficon
Inficon AG
102 patents
- Dupont Nutrition… ◀
Dupont Nutrition Biosciences APS
102 patents
What this shows Dupont holds 102 patents at rank #3,593, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Dupont
By rank, the assignees closest to #3,593 in granted patent volume.
- Bostik SA #3,589 · 102 patents
- Central South University #3,590 · 102 patents
- Colder Products Company #3,591 · 102 patents
- Corcept Therapeutics Incorporated #3,592 · 102 patents
- G.D Societa' PER Azioni #3,594 · 102 patents
- Genesis Photonics Inc. #3,595 · 102 patents
- H.C. Starck Inc. #3,596 · 102 patents
- Inficon AG #3,597 · 102 patents
Leaders in C12N (Microorganisms OR Enzymes)
Other assignees with the most granted patents in Dupont's primary technology class.
- Monsanto Technology LLC 1,335 in class
- The Regents of the University of California 1,161 in class
- Novozymes A/S 656 in class
- Immatics Biotechnologies GmbH 647 in class
- Pioneer Hi-bred International, Inc. 623 in class
- President and Fellows of Harvard College 594 in class
- Massachusetts Institute of Technology 541 in class
- The Trustees of the University of Pennsylvania 537 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Dupont, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Dupont ranks #168 of 4,144 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (56 here).
Similar claim depth
Nearest assignees by average claims per patent (16.3 here).
Dupont's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
56 Top 6% higher than 94% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 23 | 22.5% |
| 2016 | 18 | 17.6% |
| 2017 | 8 | 7.8% |
| 2018 | 10 | 9.8% |
| 2019 | 10 | 9.8% |
| 2020 | 11 | 10.8% |
| 2021 | 3 | 2.9% |
| 2022 | 10 | 9.8% |
| 2023 | 6 | 5.9% |
| 2024 | 3 | 2.9% |
Which technologies does Dupont Nutrition Biosciences APS patent most?
Top 15 of 50 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Dupont Nutrition Biosciences APS's patent record in context - here's where to go next.
- Dupont Nutrition Biosciences APS's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 59.8% of its portfolio - see every assignee active in that class. Explore C12N
- Ranked #3,593 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Dupont Nutrition Biosciences APS against Bostik SA, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 56.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.